Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bayer teams with WHF

This article was originally published in The Tan Sheet

Executive Summary

The World Heart Federation and aspirin manufacturer Bayer HealthCare have entered into a three-year partnership to "combat the rising global burden of cardiovascular disease," the corporations announce Sept. 6. The partners will educate the public and healthcare professionals on the risks of heart disease, will "help implement the Principles for National and Regional Guidelines on CVD Prevention" and will "develop initiatives aimed at primary and secondary prevention," including the promotion of low-dose aspirin for people at moderate to high risk., WHF states...





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts